Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
A double-blind, randomized, placebo controlled study evaluating the efficacy of anti-ige antibody, omalizumab, for the prevention of subsequent asthma exacerbations in children agen 6-12 years
Le Souef, Peter
(Chief Investigator)
Laing, Ingrid
(Investigator 02)
Office of DVC Research
Overview
Project Details
Status
Finished
Effective start/end date
1/08/17
→
31/07/19
Funding
Novartis Pharma AG:
A$60,000.00
View all
View less